welcome
CBS News

CBS News

Health

Health

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

CBS News
Summary
Nutrition label

83% Informative

Gilead Sciences' drug called Yeztugo is approved as a twice-yearly injection to prevent HIV.

99.9% of participants in clinical trials who received it remained HIV negative.

The drug's approval meets an existing need, but the Trump administration's funding decisions have rolled back progress for a vaccine.

VR Score

87

Informative language

88

Neutral language

67

Article tone

formal

Language

English

Language complexity

49

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links